Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

What's Behind Teva's Mixed Q1 Results


Teva Pharmaceuticals (NYSE: TEVA) started off 2021 with a bang. Its shares soared more than 30% during the first few weeks of the year. Since then, though, Teva has given up most of those gains. 

The company had an opportunity for a catalyst when Teva announced its first-quarter results before the market opened on Wednesday. However, those results didn't spark a rebound: The pharmaceutical stock slipped almost 3% in early trading. Here are the highlights from Teva's Q1 update. 

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
Share

Comments